OAM
AMAG

Oberweis Asset Management’s AMAG Pharmaceuticals AMAG Stock Holding History

Oberweis Asset Management’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-9,700
Closed -$385K – 193
2015
Q3 		$385K Hold
9,700
– – 0.11% 111
2015
Q2 		$670K Buy
+9,700
New +$610K 0.18% 61

Other funds holding AMAG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Oberweis Asset Management's AMAG Position: Q4 2015 in Review

Oberweis Asset Management sold out of AMAG Pharmaceuticals (AMAG) in Q4 2015, closing a stake of 9,700 shares — an estimated $385K sold.

Oberweis Asset Management first reported a position in AMAG in Q2 2015 and held it in 2 quarters. The position peaked at $670K in Q2 2015. 172 funds tracked by Wall St. Rank hold AMAG as of Q4 2015.

  • Oberweis Asset Management reported no remaining AMAG Pharmaceuticals position as of Q4 2015 after selling out during the quarter.
  • Oberweis Asset Management sold 9,700 AMAG Pharmaceuticals shares in Q4 2015, an estimated $385K.
  • Oberweis Asset Management first reported a position in AMAG Pharmaceuticals in Q2 2015 and held it in 2 quarters.
  • Oberweis Asset Management's AMAG Pharmaceuticals position peaked at $670K in Q2 2015.
  • 172 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2015.

Based on Oberweis Asset Management's 13F filing for Q4 2015, filed 16 Feb 2016.